ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil
- The genetic variants at the HLA-DRB1 gene are associated with primary IgA nephropathy in Han Chinese. // BMC Medical Genetics;2012, Vol. 13 Issue 1, p33
The article presents a research that investigates the correlation between Immunoglobulin A nephropathy (IgAN) and HLA-DRB1 genes in the primary IgA nephropathy in Han Chinese in Beijing, China. Researchers studied 192 patients with IgAN using PCR-SSP technique. They found that HLA-DRB1*04 is...
- Does growth hormone therapy induce IgA nephropathy? Kano, Kenichi; Nishikura, Kiyoshi; Arisaka, Osamu // Pediatric Nephrology;Dec2005, Vol. 20 Issue 12, p1821
Presents a letter to the editor regarding the capacity of growth hormone therapy to induce immunoglobulin A nephropathy.
- Renal survival in pediatric patients with IgA nephropathy. Hastings, M.; Delos Santos, Noel; Wyatt, Robert // Pediatric Nephrology;Feb2007, Vol. 22 Issue 2, p317
A letter to the editor is presented in response to the article about IgA nephropathy in children.
- T235 Variant of AGT Gene Predicts IgA Nephropathy. // Kidney;Mar/Apr98, Vol. 7 Issue 2, p59
Discusses the abstract of the article 'Association of angiotensin gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients,' by Pei Y., J. Scholey, K. Thai et al, published in the 1997 issue of the 'Journal of Clinical Investigation.'
- Megsin: The First Biologic Marker for Injured Mesangial Cells. // Kidney;Mar/Apr99, Vol. 8 Issue 2, p56
Reports on the cloning and characterization of a new human mesangium-predominant gene, megsin, a new member of the serpin superfamily that is upregulated in IgA nephropathy (IgAN), a form of mesangial proliferative glomerulephritis. Expression of megsin in normal human mesangial cells; Outcome...
- Diet Affects the Risk for IgA Nephropathy. // Kidney;Nov/Dec99, Vol. 8 Issue 6, p239
Focuses on the medical history and lifestyle risk factors for immunoglobulin A (IgA) nephropathy in Japan. Conditions found to be protective against IgA nephropathy.
- Continue Immunosuppression in Presence of MPO-ab. // Kidney;May/Jun98, Vol. 7 Issue 3, p108
Discusses the abstract of the research paper entitled 'Rapidly progressive IgA nephropathy with antimyeloperoxidase antibodies benefits from immunosuppression,' by E. Allmaras, R. Nowack et al and published in a 1997 issue of the journal 'Clinical Nephrology.'
- An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. Takemura, Tsukasa; Okada, Mitsuru; Yagi, Kazuro; Kuwajima, Hiroaki; Yanagida, Hidehiko // Pediatric Nephrology;Oct2002, Vol. 17 Issue 10, p863
We describe a patient with IgA nephropathy associated with Crohn disease. IgA nephropathy first appeared at the age of 10 years. Combined therapy with prednisolone, cyclophosphamide, warfarin, and angiotensin-converting enzyme inhibitor resulted in clinical improvement over the following year,...
- IgA nephropathy. Williams, D. Gwyn // BMJ: British Medical Journal (International Edition);1/8/94, Vol. 308 Issue 6921, p74
Discusses the clinical features of IgA nephropathy. Cause of the deposition of immunoglobulin A in the glomeruli; Production of IgA in the bone marrow; Aim of tonsillectomy in the treatment of the disease.